Brochure

Making The Complex. Simple.

GettyImages-1314459863-OSD-manufacturing-pill-tablet-capsule

At Pfizer CentreOne, simplifying complexity is at the core of how we support your oral solid dose (OSD) needs. Backed by the extensive Pfizer global network, our teams of scientific and technical experts bring decades of proven experience in developing and manufacturing high-quality OSD products—including highly potent compounds, cytotoxic agents, controlled substances, and immunosuppressants. We combine this expertise with specialized technologies such as laser drilling, multilayer coating, and orally disintegrating tablet production, all executed within state-of-the-art facilities designed to support even your most challenging OSD requirements.

To streamline OSD development and manufacturing, we offer end-to-end services built around reliability, precision, and efficiency. Our robust technology transfer process enables a seamless and accelerated start-up, while our use of process analytical technology (PAT) enhances control, reduces variability, and helps drive cost efficiencies. This integrated, “right first time” approach supports faster time to market and has contributed to our track record of delivering over 90% of projects on-time, in-full (OTIF), with zero audit issues—demonstrating our commitment to operational excellence.

With a comprehensive range of OSD manufacturing and packaging formats, we tailor our solutions to provide the optimal balance of product customization, quality, and supply reliability — so you can focus on bringing innovative therapies to patients without compromise.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online